Methods and apparatus for load balancing in high density depolyments of wireless access points according to spatial stream capabilities
    12.
    发明授权
    Methods and apparatus for load balancing in high density depolyments of wireless access points according to spatial stream capabilities 有权
    根据空间流能力,无线接入点的高密度分解负载均衡的方法和装置

    公开(公告)号:US09137724B1

    公开(公告)日:2015-09-15

    申请号:US13723550

    申请日:2012-12-21

    CPC classification number: H04W88/08 H04W28/08 H04W48/20 H04W80/04

    Abstract: A method includes receiving a signal indicative that a first access point can transmit data over a first number of spatial streams, and a second access point can transmit data over a second number of spatial streams. The method includes receiving a probe request from a set of client devices. A first portion of the set of client devices is configured to transmit data over the first number of spatial streams and a second portion of the client devices is configured to transmit data over the second number of spatial streams. The method includes sending a signal to the first portion associated with authorizing the first portion to connect to the first access point and sending a signal to the second portion associated with authorizing the second portion to connect to the second access point.

    Abstract translation: 一种方法包括接收指示第一接入点可以在第一数量的空间流上传输数据的信号,并且第二接入点可以在第二数量的空间流上传输数据。 该方法包括从一组客户端设备接收探测请求。 该组客户端设备的第一部分被配置为通过第一数量的空间流传输数据,并且客户端设备的第二部分被配置为通过第二数量的空间流传输数据。 该方法包括向与授权第一部分相关联的第一部分发送信号以连接到第一接入点,并向与授权第二部分连接到第二接入点相关联的第二部分发送信号。

    BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
    14.
    发明申请
    BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH 审中-公开
    用于治疗异常细胞生长的双相衍生物

    公开(公告)号:US20070072885A1

    公开(公告)日:2007-03-29

    申请号:US11422235

    申请日:2006-06-05

    CPC classification number: C07D239/94 C07D401/12

    Abstract: The invention relates to substantially pure compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3, R5, and X are as defined herein, and wherein the compound of formula 1 optionally further comprises a hydroxy substituent, an O-glucuronic acid, or an N−>O (N-oxide) moiety. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders that contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.

    Abstract translation: 本发明涉及基本上纯的式1化合物及其药学上可接受的盐,前药和溶剂化物,其中R 1,R 2,R 3, R 5,R 5如本文所定义,并且其中式1化合物任选地进一步包含羟基取代基,O-葡萄糖醛酸或N-(O-氧化物) )部分。 本发明还涉及通过施用式1的化合物和用于治疗含有式1化合物的这种病症的药物组合物来治疗哺乳动物异常细胞生长的方法。本发明还涉及制备式1化合物的方法。

Patent Agency Ranking